2022
Risk of SARS-CoV-2 reinfection: a systematic review and meta-analysis
Deng L, Li P, Zhang X, Jiang Q, Turner D, Zhou C, Gao Y, Qian F, Zhang C, Lu H, Zou H, Vermund S, Qian H. Risk of SARS-CoV-2 reinfection: a systematic review and meta-analysis. Scientific Reports 2022, 12: 20763. PMID: 36456577, PMCID: PMC9714387, DOI: 10.1038/s41598-022-24220-7.Peer-Reviewed Original ResearchConceptsSARS-CoV-2 reinfectionSystematic reviewReinfection incidenceHazard ratioCase reportIncidence ratePrior SARS-CoV-2 infectionSARS-CoV-2 infectionIncidence of reinfectionInfection-naïve individualsRisk of reinfectionSARS-CoV-2 variantsRandom-effects modelSARS-CoV-2Web of ScienceCohort studyReinfection riskReinfection casesPrior infectionLower riskNew infectionsOmicron variantReinfectionInfection incidenceIncidence
2019
Staying hepatitis C negative: A systematic review and meta‐analysis of cure and reinfection in people who inject drugs
Latham NH, Doyle JS, Palmer AY, Vanhommerig JW, Agius P, Goutzamanis S, Li Z, Pedrana A, Gottfredsson M, Bouscaillou J, Luhmann N, Mazhnaya A, Altice FL, Saeed S, Klein M, Falade‐Nwulia O, Aspinall E, Hutchinson S, Hellard ME, Sacks‐Davis R. Staying hepatitis C negative: A systematic review and meta‐analysis of cure and reinfection in people who inject drugs. Liver International 2019, 39: 2244-2260. PMID: 31125496, DOI: 10.1111/liv.14152.Peer-Reviewed Original ResearchConceptsSustained viral responseDirect-acting antiviralsRecent PWIDOST recipientsTreatment discontinuationPerson yearsReinfection rateRelative riskTreatment outcomesSystematic reviewIncidence of reinfectionTreatment discontinuation ratesPooled relative riskHepatitis C treatmentNewcastle-Ottawa ScaleMixed effects linear modelTherapy recipientsDiscontinuation ratesHepatitis C.Pooled incidenceViral responseCure rateRecent injectingStudy qualityPWID
2000
Incidence and Predictors of Reinfection with Trichomonas vaginalis in HIV-infected Women
Niccolai L, Kopicko J, Kassie A, Petros H, Clark R, Kissinger P. Incidence and Predictors of Reinfection with Trichomonas vaginalis in HIV-infected Women. Sexually Transmitted Diseases 2000, 27: 284-288. PMID: 10821602, DOI: 10.1097/00007435-200005000-00009.Peer-Reviewed Original ResearchConceptsPredictors of reinfectionT vaginalisIncidence of reinfectionRetrospective cohort studyTrichomonas vaginalisTransmission of HIVReinfection patternsCohort studyPerson yearsDiagnosis of trichomoniasisUninfected partnersMedical recordsStudy populationHIVReinfectionSexual partnersIncidenceWomenVaginalisSignificant predictorsTrichomoniasisHigh ratePredictorsFurther researchInfection
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply